Received: 2 July 2020
Revised: 24 July 2020
Accepted: 5 August 2020
First Online: 12 August 2020
Change Date: 24 September 2020
Change Type: Update
Change Details: This paper has been updated after publication to correct it’s Article Type (it was originally published incorrectly as a Review Article).
Compliance with ethical standards
: HE has nothing to declare. GYHL reports consultancy and speaker fees from Bayer, Bayer/Janssen, BMS/Pfizer, Biotronik, Medtronic, Boehringer Ingelheim, Microlife, Roche and Daiichi-Sankyo outside the submitted work. No fees received personally. ARP has received research funding from AstraZeneca, Celgene, Chugai, Gilead, GSK/Novartis, Napp and Roche and speaker fees and hospitality from Celgene, Gilead and Roche. The authors declare that they have no conflict of interest.